NCT06922825 2026-01-21
Pilot Study Evaluating Tumor Microenvironment Interaction in Solid Tumor Patients
Vanderbilt-Ingram Cancer Center
Phase EARLY_PHASE1 Withdrawn
Clinical Trials
55 trialsNCT07301801 2025-12-24
Clinical Application of 68Ga-FL-031 PET in the Diagnosis and Staging of Malignant Tumors
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase EARLY_PHASE1 Recruiting
NCT03433898 2025-12-19
This Study Aims to Find a Safe and Effective Dose of BI 754091. The Study Also Aims to Find Safe and Effective Doses of BI 754091 and BI 754111 in Combination. This Study is Done in Asian Patients With Different Types of Cancer
Boehringer Ingelheim
Phase EARLY_PHASE1 Completed
NCT07272603 2025-12-09
Bladder Perfusion of Plasma-Activated Saline for Bladder Cancer
Qilu Hospital of Shandong University
Phase EARLY_PHASE1 Not yet recruiting
NCT07052760 2025-10-10
Imaging of Solid Tumors Using DLL3 SPECT
University of California, San Francisco
Phase EARLY_PHASE1 Not yet recruiting
NCT05065736 2025-07-11
Using a PET Imaging Agent, 18F-Clofarabine (CFA), to Measure Deoxycytidine Kinase Activity in Metastatic Cancer
Case Comprehensive Cancer Center
Phase EARLY_PHASE1 Recruiting
NCT06419361 2025-06-04
[68Ga]Ga-Sa-DABI-4 PET Imaging of Stimulator of Interferon Gene Expression in Cancer Patients
First Affiliated Hospital of Chongqing Medical University
Phase EARLY_PHASE1 Recruiting
NCT06626711 2025-05-04
Effect of Propofol and Sevoflurane Anesthesia on HSP70 Expression in Tumor Cells
Saint Petersburg State University, Russia
Phase EARLY_PHASE1 Active not recruiting
NCT04185337 2025-02-27
Ultrasound-Guided Photoacoustic Imaging for the Detection of Metastases in Inguinal Lymph Nodes
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Completed
NCT05128838 2025-02-05
RISE (Reinvent, Integrate, Strengthen, Expand) Self-Management Program for Cancer Survivors: A Feasibility Study
Cedars-Sinai Medical Center
Phase EARLY_PHASE1 Completed
NCT06346041 2025-02-04
Safety and Efficacy of Intravenous IDOV-SAFETM in Patients With Advanced Solid Tumors
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase EARLY_PHASE1 Recruiting
NCT06782399 2025-01-17
SCC
Brigham and Women's Hospital
Phase EARLY_PHASE1 Not yet recruiting
NCT06740240 2024-12-18
68Ga-FAPI-Biotin PET/CT in Patients With Various Types of Cancer
First Affiliated Hospital of Fujian Medical University
Phase EARLY_PHASE1 Recruiting
NCT06734572 2024-12-16
18F-FAPIBiotin PET/CT: Dosimetry and Biodistribution Study
First Affiliated Hospital of Fujian Medical University
Phase EARLY_PHASE1 Recruiting
NCT06438250 2024-11-14
68Ga-JH04 PET/CT: Dosimetry and Biodistribution Studies
First Affiliated Hospital of Fujian Medical University
Phase EARLY_PHASE1 Recruiting
NCT06688188 2024-11-14
68Ga-JH12 PET/CT: Dosimetry and Biodistribution Study
First Affiliated Hospital of Fujian Medical University
Phase EARLY_PHASE1 Recruiting
NCT06688305 2024-11-14
68Ga-NI-FAPI PET/CT: First-in-human Study
First Affiliated Hospital of Fujian Medical University
Phase EARLY_PHASE1 Recruiting
NCT05141474 2024-11-07
NEXTGENTIL-ACT
Vall d'Hebron Institute of Oncology
Phase EARLY_PHASE1 Recruiting
NCT06636617 2024-10-10
177Lu-JH04 in Patients with FAP-Positive Tumors
First Affiliated Hospital of Fujian Medical University
Phase EARLY_PHASE1 Recruiting
NCT04596670 2024-08-19
68Ga-ICAM-1pep PET/CT in Cancer Patients
Peking University Cancer Hospital & Institute
Phase EARLY_PHASE1 Recruiting
NCT06455735 2024-06-12
68Ga-JH04 PET/CT in Patients With Various Types of Cancer
First Affiliated Hospital of Fujian Medical University
Phase EARLY_PHASE1 Recruiting
NCT06455761 2024-06-12
68Ga-DOTA-NI-FAPI04 PET/CT in Patients With Various Types of Cancer
First Affiliated Hospital of Fujian Medical University
Phase EARLY_PHASE1 Recruiting
NCT06431529 2024-05-28
Neoantigen-T
Jinling Hospital, China
Phase EARLY_PHASE1 Recruiting
NCT04522804 2024-03-20
HOPE
University of Utah
Phase EARLY_PHASE1 Completed
NCT06321120 2024-03-20
Using Chronobiology to Improve Lenvatinib Efficacy
Hadassah Medical Organization
Phase EARLY_PHASE1 Recruiting
NCT04294875 2024-03-06
MPT0B64
J Ints Bio
Phase EARLY_PHASE1 Withdrawn
NCT04509167 2024-03-06
Pilot Study of Neoantigen Peptides for the Treatment of Neoplasms
Instituto de Medicina Regenerativa
Phase EARLY_PHASE1 Completed
NCT03671720 2024-02-07
Personalized Vaccine Generated by Autologous Dendritic Cells Pulsed With Autologous Whole Tumor Cell Lysate Treat Advanced Solid Tumor Patients With High Tumor Mutation Burden
Capital Medical University
Phase EARLY_PHASE1 Withdrawn
NCT02469129 2023-12-12
PET Imaging of PARP Activity in Cancer
Washington University School of Medicine
Phase EARLY_PHASE1 Unknown
NCT06126705 2023-11-13
18F-AlF-FAPi-04 PET/CT Imaging in Patients With Solid Tumor
Affiliated Hospital of North Sichuan Medical College
Phase EARLY_PHASE1 Unknown
NCT05728372 2023-10-10
64Cu-DOTA Pembrolizumab for Imaging Metastatic Solid Tumors in Patients Receiving Stereotactic Body Radiation
City of Hope Medical Center
Phase EARLY_PHASE1 Withdrawn
NCT05029596 2023-09-21
Heparin Versus Normal Saline in Peripherally Inserted Central Catheter Lines
University of Texas Southwestern Medical Center
Phase EARLY_PHASE1 Completed
NCT01755650 2023-09-13
Phase 0 of 18F FPM Using PET/CT in Patients With a Variety of Malignancies
Peter MacCallum Cancer Centre, Australia
Phase EARLY_PHASE1 Terminated
NCT05490849 2023-02-22
68Ga-HX01 PET in Healthy Volunteers and Malignant Tumors Patients
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase EARLY_PHASE1 Unknown
NCT04839731 2023-02-13
Combination 5-FU / Calcipotriene Cream for SCCIS/SCC
Carilion Clinic
Phase EARLY_PHASE1 Unknown
NCT05691855 2023-01-20
89Zr-labeled NY009 PET Imaging in Patients
Affiliated Hospital of Jiangnan University
Phase EARLY_PHASE1 Unknown
NCT05691881 2023-01-20
68Ga-labeled NY105 PET Imaging in Patients
Affiliated Hospital of Jiangnan University
Phase EARLY_PHASE1 Unknown
NCT05691894 2023-01-20
Tracer Targeting FAP PET Imaging in Patients
Affiliated Hospital of Jiangnan University
Phase EARLY_PHASE1 Unknown
NCT05141253 2022-04-27
Safety and Efficacy of RD133 in Subjects With Relapsed or Refractory MSLN-Positive Solid Tumors
Tongji Hospital
Phase EARLY_PHASE1 Recruiting
NCT04721756 2022-04-25
Early Clinical Evaluation of 18F-LY3546117 in Tumor Imaging
Avid Radiopharmaceuticals
Phase EARLY_PHASE1 Unknown
NCT04882111 2021-11-11
ALIGN
University of Colorado, Denver
Phase EARLY_PHASE1 Completed
NCT04030572 2021-06-24
a2a Agonist
Weill Medical College of Cornell University
Phase EARLY_PHASE1 Terminated
NCT04702841 2021-03-08
CAR - γ δ T Cells in the Treatment of Relapsed and Refractory CD7 Positive T Cell-derived Malignant Tumors
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Phase EARLY_PHASE1 Unknown
NCT04691349 2021-01-11
CAR-T for r/r Malignant Tumors in Children
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Phase EARLY_PHASE1 Unknown
NCT04499365 2020-09-09
68Ga-FAPI PET/CT in Patients With Various Types of Cancer
First Affiliated Hospital of Fujian Medical University
Phase EARLY_PHASE1 Unknown
NCT04525612 2020-09-09
68Ga-BNU-PSMA PET/CT in Patients With Various Types of Cancer
First Affiliated Hospital of Fujian Medical University
Phase EARLY_PHASE1 Unknown
NCT03556930 2020-08-27
Simulated Radiotherapy Treatment Assisted With Pediatric Radiation Oncology With Movie Induced Sedation Effect Technique
University of Texas Southwestern Medical Center
Phase EARLY_PHASE1 Withdrawn
NCT02670941 2019-01-24
Aromatherapy for Chemotherapy-induced Symptoms
University of Rochester
Phase EARLY_PHASE1 Terminated
NCT02069080 2018-07-12
Imaging CXCR4 Expression in Subjects With Cancer Using 64 Cu-Plerixafor
National Institutes of Health Clinical Center (CC)
Phase EARLY_PHASE1 Terminated
NCT01678690 2016-09-02
An Exploratory Study of Gemcitabine Hydrochloride Oral Formulation (D07001-F4) in Subjects With Malignant Tumors
InnoPharmax Inc.
Phase EARLY_PHASE1 Completed